NCT00001628View on ClinicalTrials.gov

The Role of Angiotensin Type I Receptor in the Regulation of Human Peripheral Vascular Function

PHASE3CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 1997

Study Completion Date

September 30, 2000

Conditions
AtherosclerosisHeart Failure, CongestiveHypertensionMyocardial Infarction
Interventions
DRUG

Angiotensin II type 1 receptor antagonists

Trial Locations (1)

20892

National Heart, Lung and Blood Institute (NHLBI), Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00001628 - The Role of Angiotensin Type I Receptor in the Regulation of Human Peripheral Vascular Function | Biotech Hunter | Biotech Hunter